Cicatricial pemphigoid in the upper aerodigestive tract: Diagnosis and management in severe laryngeal stenosis

Annals of Otology, Rhinology and Laryngology

Volumn 112, Issue 3, 2003, Pages 271-275

  Boedeker, Carsten Christof ^a   Termeer, Christian Carl ^a   Staats, Richard ^a   Ridder, Gerd Jürgen ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Cicatricial pemphigoid; Differential diagnosis; Laryngeal disease; Leflunomide; Stridor; Treatment

Indexed keywords

AZATHIOPRINE; COMPLEMENT COMPONENT C3; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DAPSONE; IMMUNOGLOBULIN G; LEFLUNOMIDE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; SODIUM;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; BASEMENT MEMBRANE; BLISTER; CASE REPORT; CLINICAL FEATURE; DISEASE SEVERITY; HISTOPATHOLOGY; HUMAN; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; LARYNX STENOSIS; LARYNX TUMOR; MALE; MOUTH TUMOR; MUCOUS MEMBRANE PEMPHIGOID; NASOPHARYNX TUMOR; NOSE TUMOR; PEMPHIGOID; PRIORITY JOURNAL;

EID: 1642527390     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348940311200314     Document Type: Article

References (25)

1. Hanson RD, Olsen KD, Rogers RS III. Upper aerodigestive tract manifestations of cicatricial pemphigoid. Ann Otol Rhinol Laryngol 1988;97:493-9.
2. Cooper W. Pemphigus of the conjunctiva. Ophthalmol Hosp Rep 1857;1:155-7.
3. Thost A. Der chronische Schleimhautpemphigus der oberen Luftwege. Arch Laryngol Rhinol 1911;25:459-78.
4. Lever WF. Pemphigus. Medicine (Baltimore) 1953;32:1-123.
5. Egan CA, Yancey KB. The clinical and immunopathological manifestations of anti-epiligrin cicatricial pemphigoid, a recently defined subepithelial autoimmune blistering disease. Eur J Dermatol 2000;10:585-9.
6. Bernard P, Vaillant L, Labeille B, et al. Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Disease French Study Group. Arch Dermatol 1995;131:48-52.
7. Zillikens D, Wever S, Roth A, Weidenthaler-Barth B, Hashimoto T, Brocker EB. Incidence of autoimmune subepidermal blistering dermatoses in a region in central Germany. Arch Dermatol 1995;131:957-8.
8. Christophoridis S, Büdinger L, Borradori L, Hunziker T, Merk HF, Hertl M. IgG, IgA and IgE autoantibodies against the ectodomain of BP180 in patients with bullous and cicatricial pemphigoid and linear IgA bullous dermatosis. Br J Dermatol 2000;143:349-55.
9. Kirtschig G, Mittag H, Wolf M, Gorski A, Happle R. Three different autoimmune diseases in one family: is there a common genetic base? Br J Dermatol 1999;140:322-7.
10. Elder MJ, Lightman S, Dart JKG. Role of cyclophosphamide and high dose steroid in ocular cicatricial pemphigoid. Br J Ophthalmol 1995;79:264-6.
11. Smith RJ, Sessions RB, Bean SF. Benign mucous membrane pemphigoid. Ann Otol Rhinol Laryngol 1982;91:142-4.
12. Gaspar ZS, Wojnarowska F. Cicatricial pemphigoid with severe laryngeal involvement necessitating tracheostomy (laryngeal cicatricial pemphigoid). Clin Exp Dermatol 1996;21:209-10.
13. Yong AS, Elbom JS, Stanford CF. Cicatricial pemphigoid presenting as upper airways obstruction. Br J Clin Pract 1994;48:47-8.
14. Muller LC, Salzer GM. Stenosis of left mainstem bronchus in a case of cicatricial pemphigoid. Eur J Cardiothorac Surg 1988;2:284-6.
15. O'Donnell DE, Lam M, Webb KA. Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;158:1557-65.
16. Scully C, Carrozzo M, Gandolfo S, Puiatti P, Monteil R. Update on mucous membrane pemphigoid: a heterogeneous immune-mediated subepithelial blistering entity. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;88:56-68.
17. Ciarrocca KN, Greenberg MS. A retrospective study of the management of oral mucous membrane pemphigoid with dapsone. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;88:159-63.
18. Rogers RS III, Seehafer JR, Perry HO. Treatment of cicatricial (benign mucous membrane) pemphigoid with dapsone. J Am Acad Dermatol 1982;6:215-23.
19. Musette P, Pascal F, Hoang-Xuan T, et al. Treatment of cicatricial pemphigoid with pulse intravenous cyclophosphamide. Arch Dermatol 2001;137:101-2.
20. Geilen CC, Orfanos-Boeckel H, Offermann G, Orfanos CE. Mycophenolate mofetil: a new immunosuppressive drug in dermatology and its possible uses [in German]. Hautarzt 2000;51:63-9.
21. Zurdel J, Aboalchamat B, Zierhut M, Stubiger N, Bialasiewicz A, Engelmann K. Early clinical results with mycophenolate mofetil in immunosuppressive therapy of ocular pemphigoid [in German]. Klin Monatsbl Augenheilkd 2001;218:222-8.
22. Böhm M, Beissert S, Schwarz T, Metze D, Luger T. Bullous pemphigoid treated with mycophenolate mofetil. Lancet 1997;349:541.
23. Reece RJ, Kraan MC, Radjenovic A, et al. Comparative assessment of leflunomide and methotrexate for the treatment of rheumatoid arthritis, by dynamic enhanced magnetic resonance imaging. Arthritis Rheum 2002;46:366-72.
24. Remer CF, Weisman MH, Wallace DJ. Benefits of leflunomide in systemic lupus erythematosus: a pilot observational study. Lupus 2001;10:480-3.
25. Williams JW, Mital D, Chong A, et al. Experiences with leflunomide in solid organ transplantation. Transplantation 2002;73:358-66.